- €8.20bn
- €10.91bn
- €15.17bn
Brief: Brenntag's CEO: 90-Day Tariff Moratories Will Not Lessen Uncertainty -Conf Call
Brenntag falls after Q1 profit miss amid global economic uncertainty
Brenntag posts quarterly core profit below expectations (updated)
Brenntag posts quarterly core profit below expectations
Europe Research Roundup: Aixtron, Bayer, Cerillion
Brief: Brenntag Proposes An Expansion Of The Supervisory Board To Eight Members
Wrapup 2: Corporate gloom deepens as new Trump tariffs take effect
Brief: Brenntag's CEO says North American Business To Be Comparatively Little Affected By Potential Tariffs And Duties -Conf Call
Brenntag falls on weaker than expected Q4 core profit
Brenntag forecasts at least stable core profit for 2025 in tough environment (updated)
Brenntag forecasts at least stable core profit for 2025 in tough environment
Brief: Brenntag Specialties And Royal Avebe Further Expand Their Strategic Partnership For Food & Nutrition To Poland
Brief: Brenntag Announces Exclusive Partnership With Hipromine To Distribute Insect-Based Products
Brief: Brenntag Says Brenntag Specialties Announces Exclusive Distribution Agreement With Meggle Excipients For Pharmaceutical-Grade Lactose In Benelux And Nordics
Brief: Brenntag Appoints Thomas Reisten As CFO As Of April 1, 2025
Europe Research Roundup: Antofagasta, NOS, SSE
Barclays upgrades IMCD, Brenntag as it looks for growth in chemicals market
MS sees M&A, US revenues boosting European business services in 2025
Brief: Brenntag Specialties Partners With Cambrium To Introduce ‘Novacoll’ In Europe